Evan Yu, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Amgen
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pharmacyclics
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Daiichi Sankyo
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Agensys
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Agensys
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merck
    Date added:
    Date updated:
    12/22/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    12/22/2021

Pages

Return to Evolving Role of the Urologist in Metastatic and Castration Resistant Prostate Cancer: A Guidelines and Case-Based Discussion - Washington, D.C. (2019)